Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 12, 2022

SELL
$1.76 - $4.84 $20,768 - $57,112
-11,800 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$4.17 - $9.79 $21,267 - $49,928
-5,100 Reduced 30.18%
11,800 $22,000
Q3 2021

Nov 10, 2021

BUY
$8.86 - $17.05 $26,580 - $51,150
3,000 Added 21.58%
16,900 $80,000
Q2 2021

Aug 11, 2021

BUY
$3.75 - $78.5 $52,125 - $1.09 Million
13,900 New
13,900 $64,000

Others Institutions Holding BTX

# of Institutions
1
Shares Held
1.21M
Call Options Held
0
Put Options Held
0

About Brooklyn ImmunoTherapeutics, Inc.


  • Ticker BTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,825,700
  • Description
  • Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy techno...
More about BTX
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.